natural killer cell
AACR: Affimed builds case for natural killer cell therapy
Phil Taylor
Affimed, bispecific antibody, classical Hodgkin lymphoma, immuno-oncology, natural killer cell, non-Hodgkin lymphoma, Oncology
0 Comment
X
AACR: Affimed builds case for natural killer cell therapy
https://pharmaphorum.com/news/aacr-affimed-builds-case-for-natural-killer-cell-therapy/
Gilead combs Shoreline for NK cell therapies in $2.3bn alliance
Phil Taylor
car-nk, cell therapy, Gilead Sciences, immuno-oncology, Kite Pharma, natural killer cell, Oncology, Shoreline Bioscience
0 Comment
X
Gilead combs Shoreline for NK cell therapies in $2.3bn alliance
https://pharmaphorum.com/news/gilead-combs-shoreline-for-nk-cell-therapies-in-2-3bn-alliance/